Octopus BiosafetySTU:OCR 6 PS Ratio is 25.00 as of Jul. 11, 2026, which is 29% below its 10-year median of 35.38. GuruFocus rates STU:OCR with a GF Score™ of 6/100 and a GF Value™ of €0.04. The stock has 2 warning signs investors should review. Among 2,471 Hardware companies, Octopus Biosafety ranks worse than 97.69% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Octopus Biosafety's share price is €0.10.
Octopus Biosafety's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Hence, Octopus Biosafety's PS Ratio for today is 25.00.
The historical rank and industry rank for Octopus Biosafety's PS Ratio or its related term are showing as below:
STU:OCR'
s PS Ratio Range Over the Past 10 Years
Min: 8 Med: 35.38 Max: 125
Current: 45
During the past 10 years, Octopus Biosafety's highest PS Ratio was 125.00. The lowest was 8.00. And the median was 35.38.
STU:OCR's PS Ratio is ranked worse than 97.69% of 2471
companies
in the Hardware industry
Industry Median: 1.92
vs STU:OCR: 45.00
During the past 10 years, Octopus Biosafety's highest 3-Year average Revenue per Share Growth Rate was -35.20% per year. The lowest was -38.30% per year. And the median was -36.75% per year.
Back to Basics: PS Ratio
Octopus Biosafety (STU:OCR) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Octopus Biosafety PS Ratio Related Terms
Octopus Biosafety PS Ratio Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Computer Hardware subindustry, Octopus Biosafety's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety PS Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's PS Ratio distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Octopus Biosafety's Share Price of today is €0.10.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Octopus Biosafety (STU:OCR) has a PS Ratio of 25.00 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Octopus Biosafety and its competitors. This is 29% below median its historical median of 35.38. Over the past decade, Octopus Biosafety's PS Ratio has ranged from 8.00 to 125.00. According to the industry distribution chart, Octopus Biosafety ranks #2414 out of 2471 companies in the Hardware industry, placing it in the top 97.7%.
Is Octopus Biosafety's PS Ratio too high?
Octopus Biosafety's current PS Ratio of 25.00 is 29% below median its 10-year median of 35.38. Over the past 10 years, this metric has ranged from a low of 8.00 to a high of 125.00. The Hardware industry median PS Ratio is 1.92. Octopus Biosafety's value of 25.00 is 1202.1% above this industry median. Based on the distribution chart, Octopus Biosafety ranks #2414 out of 2471 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's PS Ratio compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2414 out of 2471 companies for PS Ratio. This places Octopus Biosafety in the lower half of its industry. The industry median PS Ratio is 1.92. Octopus Biosafety's value of 25.00 is 1202.1% above this benchmark. Historically, Octopus Biosafety's own PS Ratio has ranged from 8.00 to 125.00 over the past decade. While the company's 10-year median is 35.38 vs. the industry median of 1.92, Octopus Biosafety has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Hardware company?
The median PS Ratio among Hardware companies is 1.92, based on 2,471 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Octopus Biosafety's current PS Ratio of 25.00 is 1202.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median PS Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current PS Ratio is 25.00, which is 29% below median its own 10-year median of 35.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current PS Ratio of 25.00. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 150% above its estimated fair value. The current PS Ratio is 25.00, which is 29% below median its 10-year median of 35.38 and 1202.1% above the Hardware industry median of 1.92. Octopus Biosafety's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current PS Ratio is 25.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 150% above its estimated GF Value™ of €0.04.
Key valuation signals for STU:OCR:
PS Ratio: 25.00 (29% below median its 10-year median of 35.38)
GF Value™: €0.04 vs. price of €0.10 (150% above fair value)
Industry Position: 1202.1% above the Hardware median (#2414 of 2471)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
6GF Score
Get the complete analysis for STU:OCR
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
